Screener
INmune Bio INMB Q2 2026 earnings
Reported August 6, 2026 · After market close
EPS-$0.05Beat by $0.16
Revenue estimate$1.2M
EPS estimate-$0.21
Next report
Oct 29, 2026 (in 2 months)Revenue estimate$1.9M
EPS estimate-$0.15
Versus estimates
Revenue
Diluted EPS
FAQ
- When did INmune Bio report Q2 2026 earnings?
- INmune Bio (INMB) reported Q2 2026 earnings on August 6, 2026 after market close.
- What were INmune Bio's Q2 2026 revenue and EPS?
- INmune Bio reported eps of $-0.05 for Q2 2026.
- Did INmune Bio beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.21 by $0.16.
- How did INmune Bio's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 85.3% from $-0.34.
- Where can I find INmune Bio's Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001213900-26-086135) directly on SEC EDGAR. The filing index links above go to sec.gov.
